First Edition: December 11, 2017
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
30,501 - 30,520 of 112,168 Results
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from news outlets around the country.
Media outlets report on news from Massachusetts, New York, Florida, New Jersey, Ohio, Minnesota and Wisconsin.
Here is a selection of news coverage of other recent research:
Even doctors, who know when it's necessary, procrastinate about seeking medical care. The Boston Globe looks at why we do this. In other public health news: gene editing, diabetes, marijuana, suicide, arsenic, smog and more.
The program is distributing millions of dollars to companies to develop solutions such as implants that could someday relieve pain without relying upon opioids and a medication that’s designed to use the body’s natural digestive process to prevent overdoses.
So far, the strain that is most common is the one that is less vulnerable to vaccines. But officials say that, even so, it's still worth getting the shot.
African American women disproportionately experience complications from pregnancy and child birth. ProPublica talks to 10 mothers about their experiences as part of an investigation into why it's happening.
Researchers have always struggled with the correlation between deaths and the presence of guns in homes. But the 2012 tragedy -- and the rush of sales that followed -- allowed them an insight into the ramifications of more Americans owning guns.
Dignity Health, headquartered in San Francisco, and Catholic Health Initiatives, based in Denver, have signed a merger agreement. The combined system will have 139 hospitals around the country.
The issue of the organization's fetal tissue practices was thrust into the spotlight in 2015 when undercover videos purporting to show Planned Parenthood officials discussing procurement of "intact" and partial fetuses in exchange for compensation for expenses.
The group of lawmakers looking to save the 340B program is made up of both Democrats and Republicans. In other pharmaceutical news: an analysis shows that many drugmakers are behind on required post-marketing studies; the Supreme Court shows interest in taking up the product liability issue; Sage announces positive results from its depression drug trial; and more.
Lawmakers are starting to prod leadership about the lack of movement over money for the popular program.
The tax bill is expected to add $1 trillion to the deficit and that will trigger a mechanism that makes automatic cuts in federal spending. The nonpartisan Congressional Budget Office estimates that would take a $25 billion bite out of the Medicare budget.
The borrowing spree is happening as Congress debates whether to do away with long-held tax exemptions on these types of bonds beginning Jan. 1. Meanwhile, lawmakers are mulling what to do about the health law's insurance tax.
The companies may have to return any surplus they used to cover cost-sharing reduction costs since the Trump administration cut off the payments in October.
Sen. Susan Collins (R-Maine) threw her support behind the Republican tax bill on the agreement that the Senate would take up the bipartisan health legislation that is aimed at stabilizing the marketplace. But even though she extracted the promise from Senate Majority Leader Mitch McConnell, the rest of the GOP leadership isn't ready with uphold the bargain.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
© 2026 KFF